Background and Aims: Both non-alcoholic fatty liver disease (NAFLD) and depression have
a high global prevalence which is projected to increase further. While studies exploring the …

Nonalcoholic fatty liver disease (NAFLD), also recently referred as metabolic (dysfunction)-
associated fatty liver disease (MAFLD), is characterized by hepatocyte steatosis in the …

Background Depression is prevalent among individuals with non-alcoholic fatty liver disease
(NAFLD) and can cause poor health outcomes. Moreover, a solid bilateral association …

Bile components play a critical role in maintaining gut microbiota homeostasis. In
cholestasis, bile secretion is impaired, leading to liver injury. However, it remains to be …

Abstract Introduction Metabolic Syndrome (MetS) and depression comorbidity has been
recognized, but its directionality is still uncertain. The aims of this study was to assess the …

Depression and metabolic diseases often coexist, having several features in common, eg,
chronic low-grade inflammation and intestinal dysbiosis. Different microbiota interventions …

Adverse childhood experiences (ACEs) have a long-lasting effect on both physical and
mental health. The aim of this study was to assess the consequences of ACEs and …

There is a huge need to search for new treatment options and potential biomarkers of
therapeutic response to antidepressant treatment. Depression and metabolic syndrome …

Background Individuals with depression and depressive symptoms have a higher mortality
rate than non‐depressed individuals. The increased comorbidity and mortality associated …

Background With the global rise in obesity, metabolic dysfunction-associated steatotic liver
disease (MASLD) has emerged as the most common chronic liver disease. Concurrently …